# EffectiveNess of Low-dose Aspirin in Prevention of Cancer in the Stomach and Oesophagus (GastrointEstinal Cancer Prevention) - United Kingdom ("ENgAGE - UK"): Study to Evaluate the Risk of Cancer in the Stomach and Oesophagus Among New Users of Low-dose Aspirin Using the THIN Database in the UK

> **NCT03743883** · — · COMPLETED · sponsor: **Bayer** · enrollment: 99999 (actual)

## Conditions studied

- Prevention of Oesophagus Cancer and Stomach Cancer

## Interventions

- **DRUG:** Acetylsalicylic Acid(BAYE4465, Aspirin )

## Key facts

- **NCT ID:** NCT03743883
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-30
- **Primary completion:** 2019-04-15
- **Final completion:** 2019-05-31
- **Target enrollment:** 99999 (ACTUAL)
- **Last updated:** 2020-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03743883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03743883, "EffectiveNess of Low-dose Aspirin in Prevention of Cancer in the Stomach and Oesophagus (GastrointEstinal Cancer Prevention) - United Kingdom ("ENgAGE - UK"): Study to Evaluate the Risk of Cancer in the Stomach and Oesophagus Among New Users of Low-dose Aspirin Using the THIN Database in the UK". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03743883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*